0.888
price down icon1.17%   -0.0105
after-market アフターアワーズ: .90 0.012 +1.35%
loading

180 Life Sciences Corp (ATNF) 最新ニュース

pulisher
Apr 19, 2025

Alliancebernstein L.P. Has $1.12 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World

Apr 19, 2025
pulisher
Apr 15, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 15, 2025
pulisher
Apr 14, 2025

Arrowstreet Capital Limited Partnership Has $312,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Apr 14, 2025
pulisher
Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Best Penny Stocks for Today (Charts Updated Daily) - Benzinga

Apr 11, 2025
pulisher
Apr 09, 2025

Elray Resources Announces Strategic Sale of Crypto iGaming Technology - ADVFN

Apr 09, 2025
pulisher
Apr 09, 2025

Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews

Apr 09, 2025
pulisher
Apr 09, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF) - Defense World

Apr 09, 2025
pulisher
Apr 09, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reaffirmed at Weiss Ratings - The AM Reporter

Apr 09, 2025
pulisher
Apr 08, 2025

ATNF stock touches 52-week low at $0.74 amid market shifts - Investing.com India

Apr 08, 2025
pulisher
Apr 08, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 08, 2025
pulisher
Apr 05, 2025

180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors - ACCESS Newswire

Apr 05, 2025
pulisher
Mar 31, 2025

180 Life Sciences Corp. SEC 10-K Report - TradingView

Mar 31, 2025
pulisher
Mar 31, 2025

ATNF stock touches 52-week low at $0.98 amid market shifts - Investing.com

Mar 31, 2025
pulisher
Mar 30, 2025

Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Increases By 67.2% - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

180 Life Sciences (NASDAQ:ATNF) versus Immunic (NASDAQ:IMUX) Head to Head Comparison - Defense World

Mar 28, 2025
pulisher
Mar 24, 2025

Motor Neuron Disease Clinical Pipeline | 180+ Companies Advancing Next-Generation Therapies - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

180 Life Sciences (NASDAQ:ATNF) Given Sell (E+) Rating at Weiss Ratings - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

180 Degree Capital (NASDAQ:TURN) Given Sell (D-) Rating at Weiss Ratings - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Synergy CHC (SNYR) Projected to Post Earnings on Monday - Defense World

Mar 24, 2025
pulisher
Mar 19, 2025

Zydus Lifesciences shares rally 3% after FDA approval for prostate cancer drug - The Economic Times

Mar 19, 2025
pulisher
Mar 17, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 29.3% in February - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

Janone Inc. (NASDAQ:ALTS) Short Interest Up 40.9% in February - Defense World

Mar 17, 2025
pulisher
Mar 17, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Sees Large Growth in Short Interest - Armenian Reporter

Mar 17, 2025
pulisher
Mar 11, 2025

ATNF stock touches 52-week low at $1.1 amid market fluctuations - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Contract wins and repeat business fuel progress at life sciences company - The Business Desk

Mar 11, 2025
pulisher
Mar 08, 2025

180 Life Sciences’ (ATNF) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

Mar 08, 2025
pulisher
Mar 02, 2025

180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Down 50.4% in February - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

Short Interest in ArrowMark Financial Corp. (NASDAQ:BANX) Expands By 62.6% - Defense World

Mar 02, 2025
pulisher
Mar 02, 2025

American Rebel Holdings, Inc. (NASDAQ:AREB) Sees Large Growth in Short Interest - Defense World

Mar 02, 2025
pulisher
Feb 27, 2025

ATNF stock touches 52-week low at $1.14 amid market shifts - Investing.com India

Feb 27, 2025
pulisher
Feb 27, 2025

Global Dupuytrens Disease Market Deep Research 2025-2032 | Endo - openPR

Feb 27, 2025
pulisher
Feb 21, 2025

180 Life Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025
pulisher
Feb 20, 2025

180 Life Sciences (NASDAQ:ATNF) Receives Sell (E+) Rating from Weiss Ratings - Armenian Reporter

Feb 20, 2025
pulisher
Feb 20, 2025

180 Life Sciences (NASDAQ:ATNF) Given “Sell (E+)” Rating at Weiss Ratings - Defense World

Feb 20, 2025
pulisher
Feb 14, 2025

TURN180 Degree Capital Corp Latest Stock News & Market Updates - StockTitan

Feb 14, 2025
pulisher
Feb 13, 2025

180 Life Sciences Corp. modifies former CEO's exit terms - MSN

Feb 13, 2025
pulisher
Feb 08, 2025

180 Life Sciences Corp. modifies former CEO’s exit terms By Investing.com - Investing.com India

Feb 08, 2025
pulisher
Feb 07, 2025

180 Life Sciences Corp. modifies former CEO's exit terms By Investing.com - Investing.com Canada

Feb 07, 2025
pulisher
Feb 07, 2025

180 Life Sciences Appoints New CEO Amid Leadership Changes - TipRanks

Feb 07, 2025
pulisher
Feb 05, 2025

Anavex Q1 2025 Earnings: Strategic Growth Updates Coming February 12 - StockTitan

Feb 05, 2025
pulisher
Feb 04, 2025

180 Life Sciences (NASDAQ:ATNF) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World

Feb 04, 2025
pulisher
Jan 29, 2025

Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y - Yahoo Finance

Jan 29, 2025
pulisher
Jan 27, 2025

Sai Life Sciences Shares Continue To Decline, Slumps Over 11% In A Week Despite Expansion Plans - Free Press Journal

Jan 27, 2025
pulisher
Jan 25, 2025

180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 24, 2025

180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Jan 24, 2025
pulisher
Jan 24, 2025

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why - Nasdaq

Jan 24, 2025
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
大文字化:     |  ボリューム (24 時間):